Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Grohmann

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|September 5, 1998
Risk factors for suicides of inpatients with depressive psychosesM Krupinski, A Fischer, R Grohmann, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1986
Adverse drug reactions to first- and second-generation antidepressants: a critical evaluation of drug surveillance dataL G Schmidt, R Grohmann, B Müller-Oerlinghausen, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Consistency of assessment of adverse drug reactions in psychiatric hospitals: a comparison of an algorithmic and an empirical approachL G Schmidt, P Dirschedl, R Grohmann, et al.
Psychopharmacology|September 27, 2013
Seizures during antidepressant treatment in psychiatric inpatients--results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008M Köster, R Grohmann, R R Engel, et al.
Clinical Pharmacology and Therapeutics|August 26, 2011
Evaluation of drug interactions in a large sample of psychiatric inpatients: a data interface for mass analysis with clinical decision support softwareP Haueis, W Greil, M Huber, et al.
Der Nervenarzt|December 5, 2000
[Schizophrenic psychoses and suicide in the clinic. Risk factors, psychopharmacologic treatment]M Krupinski, A Fischer, R Grohmann, et al.
Pharmacopsychiatry|March 31, 2004
Severe adverse drug reactions in psychiatric inpatients treated with neurolepticsS Bender, R Grohmann, R R Engel, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1989
Prevalence of benzodiazepine abuse and dependence in psychiatric in-patients with different nosology. An assessment of hospital-based drug surveillance dataL G Schmidt, R Grohmann, B Müller-Oerlinghausen, et al.
Der Nervenarzt|June 4, 2020
[Psychopharmacotherapy during the COVID-19 pandemic]J Seifert, J Heck, G Eckermann, et al.
The International Journal of Neuropsychopharmacology|September 19, 2013
History, background, concepts and current use of comedication and polypharmacy in psychiatryH-J Möller, F Seemüller, R Schennach-Wolff, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
European Archives of Psychiatry and Clinical Neuroscience|September 5, 1998
Risk factors for suicides of inpatients with depressive psychosesM Krupinski, A Fischer, R Grohmann, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1986
Adverse drug reactions to first- and second-generation antidepressants: a critical evaluation of drug surveillance dataL G Schmidt, R Grohmann, B Müller-Oerlinghausen, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Consistency of assessment of adverse drug reactions in psychiatric hospitals: a comparison of an algorithmic and an empirical approachL G Schmidt, P Dirschedl, R Grohmann, et al.
Psychopharmacology|September 27, 2013
Seizures during antidepressant treatment in psychiatric inpatients--results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008M Köster, R Grohmann, R R Engel, et al.
Clinical Pharmacology and Therapeutics|August 26, 2011
Evaluation of drug interactions in a large sample of psychiatric inpatients: a data interface for mass analysis with clinical decision support softwareP Haueis, W Greil, M Huber, et al.
Der Nervenarzt|December 5, 2000
[Schizophrenic psychoses and suicide in the clinic. Risk factors, psychopharmacologic treatment]M Krupinski, A Fischer, R Grohmann, et al.
Pharmacopsychiatry|March 31, 2004
Severe adverse drug reactions in psychiatric inpatients treated with neurolepticsS Bender, R Grohmann, R R Engel, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1989
Prevalence of benzodiazepine abuse and dependence in psychiatric in-patients with different nosology. An assessment of hospital-based drug surveillance dataL G Schmidt, R Grohmann, B Müller-Oerlinghausen, et al.
Der Nervenarzt|June 4, 2020
[Psychopharmacotherapy during the COVID-19 pandemic]J Seifert, J Heck, G Eckermann, et al.
The International Journal of Neuropsychopharmacology|September 19, 2013
History, background, concepts and current use of comedication and polypharmacy in psychiatryH-J Möller, F Seemüller, R Schennach-Wolff, et al.
Pageof 9